Franklin Resources
RAPT

Franklin Resources’s RAPT Therapeutics RAPT Stock Holding History

Franklin Resources’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,235
Closed -$232K – 2950
2024
Q1 		$232K Buy
+3,235
New +$450K ﹤0.01% 2547
2022
Q4 		– Sell
-1,084
Closed -$209K – 2371
2022
Q3 		$209K Buy
+1,084
New +$205K ﹤0.01% 1982
2022
Q2 		– Sell
-1,588
Closed -$280K – 2443
2022
Q1 		$280K Buy
1,588
+2
+0.1% +$378 ﹤0.01% 2048
2021
Q4 		$466K Sell
1,586
-2
-0.1% -$535 ﹤0.01% 1927
2021
Q3 		$394K Buy
+1,588
New +$420K ﹤0.01% 1978

Other funds holding RAPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Franklin Resources's RAPT Position: Q2 2024 in Review

Franklin Resources sold out of RAPT Therapeutics (RAPT) in Q2 2024, closing a stake of 3,235 shares — an estimated $232K sold.

Franklin Resources first reported a position in RAPT in Q3 2021 and held it in 5 quarters. The position peaked at $466K in Q4 2021. 103 funds tracked by Wall St. Rank hold RAPT as of Q2 2024.

  • Franklin Resources reported no remaining RAPT Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Franklin Resources sold 3,235 RAPT Therapeutics shares in Q2 2024, an estimated $232K.
  • Franklin Resources first reported a position in RAPT Therapeutics in Q3 2021 and held it in 5 quarters.
  • Franklin Resources's RAPT Therapeutics position peaked at $466K in Q4 2021.
  • 103 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2024.

Based on Franklin Resources's 13F filing for Q2 2024, filed 14 Aug 2024.